- Page 4: ContentsEditorial GroupAcknowledgem
- Page 9 and 10: Editorial GroupRoy FootLead Pharmac
- Page 11 and 12: IntroductionWelcome to the sixth ed
- Page 13 and 14: Good prescribing practice - General
- Page 15 and 16: Controlled Drug PrescribingThe legi
- Page 18 and 19: and information on QT interval prol
- Page 20 and 21: NHSGGC Adult Formularywww.ggcprescr
- Page 22 and 23: Unlicensed MedicinesNo medicine can
- Page 24 and 25: U&Es...............................
- Page 26 and 27: Page 16
- Page 28 and 29: Management of AnaphylaxisResuscitat
- Page 30 and 31: Cardiopulmonary ResuscitationResusc
- Page 32 and 33: Tachycardia - treatment algorithm (
- Page 34 and 35: Bradycardia - treatment algorithmRe
- Page 36 and 37: Resuscitation and AnaphylaxisTransf
- Page 38 and 39: Blood productsResuscitation and Ana
- Page 40 and 41: Table continued from previous pageS
- Page 42 and 43: Management of Acute Kidney Injury (
- Page 44 and 45: Resuscitation and AnaphylaxisManage
- Page 46 and 47: General Management of Overdosesand
- Page 48 and 49: Drug Overdose and ToxicityManagemen
- Page 51 and 52: Guideline updated 07/10/13Reversal
- Page 53 and 54: Section 3Gastrointestinal SystemGas
- Page 55:
Management of ConstipationIntroduct
- Page 58 and 59:
Management of Helicobacter pyloriGa
- Page 60 and 61:
Management of Gastro-oesophageal Re
- Page 62 and 63:
Gastrointestinal SystemUpper GI Hae
- Page 64 and 65:
Management of Severe Exacerbation o
- Page 66 and 67:
Management of Decompensated Liver D
- Page 68 and 69:
Gastrointestinal SystemGeneral mana
- Page 70 and 71:
Management of Suspected Variceal Bl
- Page 72 and 73:
Guideline updated 07/10/13Managemen
- Page 74 and 75:
Gastrointestinal SystemGeneral mana
- Page 76 and 77:
Thromboprophylaxis for Medicaland S
- Page 78 and 79:
Cardiovascular SystemGeneral manage
- Page 80 and 81:
Continued from previous pageCardiov
- Page 82 and 83:
Initial management• Seek immediat
- Page 84 and 85:
Low Risk(Score 0 - 3)Perform D-dime
- Page 86 and 87:
Drug therapy / treatment options co
- Page 88 and 89:
Cardiovascular SystemWarfarin flexi
- Page 90 and 91:
Prevention and Management of Venous
- Page 92 and 93:
Drug therapy / treatment optionsTre
- Page 94 and 95:
Cardiovascular SystemPatients recen
- Page 96 and 97:
Cardiovascular SystemGeneral manage
- Page 98 and 99:
Management Plan for Patients on War
- Page 100 and 101:
Cardiovascular SystemElective admis
- Page 103 and 104:
Management of Suspected Acute Coron
- Page 105 and 106:
Initial management of STEMI present
- Page 107 and 108:
Interventional Cardiology Referral
- Page 109 and 110:
Continued from previous pageCalcium
- Page 111 and 112:
Table 1 - Antiplatelet dual therapy
- Page 113 and 114:
Secondary Prevention of Coronary He
- Page 115 and 116:
Atrial Fibrillation (AF) or Flutter
- Page 117 and 118:
Atrial Fibrillation (AF) - Persiste
- Page 119 and 120:
Prevention of stroke / thromboembol
- Page 121 and 122:
Drugs for atrial fibrillationSee gu
- Page 123 and 124:
Management of Acute Pulmonary Oedem
- Page 125 and 126:
CPAP algorithmSpO 2< 90 % on high f
- Page 127 and 128:
Management of Acute Stroke 1Present
- Page 129 and 130:
Management of Acute Stroke 2The fir
- Page 131 and 132:
• Reconsider potential indication
- Page 133 and 134:
• Prescribe:Aspirin oral 300 mg l
- Page 135 and 136:
Blood Pressure (BP)After the acute
- Page 137 and 138:
Section 5Respiratory SystemRespirat
- Page 139 and 140:
Interpretation of blood gasesFirst
- Page 141 and 142:
Guidelines on Oxygen and OximetryGu
- Page 143 and 144:
threatening attacks may not be dist
- Page 145 and 146:
Continued from previous pageMONITOR
- Page 147 and 148:
Drug therapy / treatment options co
- Page 149 and 150:
Treatment optionsTreatment: immedia
- Page 151:
Non-Invasive Ventilation (NIV) Prot
- Page 154 and 155:
Step 6 - Treatment failure• Indic
- Page 156 and 157:
• Anticoagulation (raised prothro
- Page 158 and 159:
Management of PneumoniaRespiratory
- Page 160 and 161:
Treatment options continuedDischarg
- Page 162 and 163:
Management of Spontaneous Pneumotho
- Page 164 and 165:
Treatment / drug therapy continuedI
- Page 166 and 167:
Treatment / drug therapy• Treatme
- Page 168 and 169:
General Principles of Acute Pain Ma
- Page 170:
Paracetamol IV continuedAdministrat
- Page 173 and 174:
Analgesics for acute pain - prescri
- Page 175:
Drug therapyThe table below is a ge
- Page 178 and 179:
Central Nervous SystemImmediate non
- Page 180 and 181:
Central Nervous SystemPharmacologic
- Page 182 and 183:
Management of DepressionN.B. MHRA h
- Page 184 and 185:
Continued from previous pageBaselin
- Page 186 and 187:
Vitamin Prophylaxis and Treatment o
- Page 188 and 189:
Management of Drug Misusers in Hosp
- Page 190 and 191:
Treatment options(N.B. All these me
- Page 192 and 193:
Crisis management prescribing for b
- Page 194 and 195:
Suspected SAHYESDoes the patient ha
- Page 196 and 197:
Guidelines for the Management of Pa
- Page 198 and 199:
SIGN 110. Early management of adult
- Page 200 and 201:
Patients with generalised tonic-clo
- Page 202 and 203:
Guideline for Phenytoin Dose Calcul
- Page 204 and 205:
Continued from previous pageN.B. Ta
- Page 206 and 207:
Parkinson’s Disease in Acute Care
- Page 208 and 209:
Central Nervous SystemPage 198
- Page 210 and 211:
Management of infectionsIntroductio
- Page 212 and 213:
Factors associated with CDI continu
- Page 214 and 215:
Antibiotic Allergy and Interactions
- Page 216 and 217:
Table 1 - Antibiotic IV to oral swi
- Page 218 and 219:
Table 1 - Alert AntibioticsInfectio
- Page 220 and 221:
Table 1 - Alert Antibiotics continu
- Page 222 and 223:
Sepsis Source Unknown (not immunoco
- Page 224 and 225:
Immunocompromised patients with fev
- Page 226 and 227:
Endocarditis• Take three sets of
- Page 228 and 229:
Guideline updated 08/11/13Urinary t
- Page 230 and 231:
InfectionsUTI in non-pregnant women
- Page 232 and 233:
InfectionsTable continued from prev
- Page 234 and 235:
Table continued from previous page
- Page 236 and 237:
Upper respiratory tract infectionsU
- Page 238 and 239:
Table continued from previous pageU
- Page 240 and 241:
Lower respiratory tract infections
- Page 242 and 243:
Pneumonia (continued from previous
- Page 244 and 245:
Pneumonia (continued from previous
- Page 247 and 248:
Table continued from previous pageI
- Page 249 and 250:
Management of suspected Clostridium
- Page 251 and 252:
Skin and soft tissue infections•
- Page 253 and 254:
Skin and soft tissue infections (co
- Page 255 and 256:
Bone and joint infection• Discuss
- Page 257 and 258:
Bacterial meningitis continuedBacte
- Page 259 and 260:
Brain abscess• Perform blood cult
- Page 261 and 262:
Viral infections (continued from pr
- Page 263 and 264:
Genito-urinary infections (continue
- Page 265 and 266:
HIV infection in hospital• Contac
- Page 267 and 268:
Outpatient Parenteral Antibiotic Th
- Page 269 and 270:
Surgical Antibiotic ProphylaxisThe
- Page 271 and 272:
Amikacin dosing guidelines (For pat
- Page 273 and 274:
Step 1 continued from previous page
- Page 275 and 276:
Step 3: Assess daily: the ongoing n
- Page 277 and 278:
Vancomycin maintenance intermittent
- Page 279 and 280:
Toxicity• Monitor creatinine dail
- Page 281 and 282:
Continued from previous pageStep 2:
- Page 283 and 284:
Teicoplanin dosing guidelines (For
- Page 285 and 286:
Section 9Endocrine SystemEndocrine
- Page 287 and 288:
Continued from previous page• 0.9
- Page 289 and 290:
Management of HyperglycaemicHyperos
- Page 291 and 292:
General management and drug therapy
- Page 293 and 294:
Management of Diabetes for People R
- Page 295 and 296:
Bolus feeding -1. The feed is divid
- Page 297 and 298:
Insulin sliding scale, continuedPot
- Page 299 and 300:
General management and drug therapy
- Page 301 and 302:
Types of Antidiabetic DrugsInjectab
- Page 303 and 304:
Management of Adrenal Insufficiency
- Page 305 and 306:
Section 9Electrolyte DisturbancesEl
- Page 308 and 309:
Management of Hypokalaemia (plasma
- Page 310 and 311:
Management of HypomagnesaemiaN.B. U
- Page 312 and 313:
Management of HypophosphataemiaIntr
- Page 314 and 315:
Management of HypercalcaemiaThis gu
- Page 316 and 317:
Management of HypocalcaemiaIntroduc
- Page 318 and 319:
Management of HypernatraemiaSerum N
- Page 320 and 321:
Management of GoutIntroductionGout
- Page 322 and 323:
Management of ArthritisIntroduction
- Page 324 and 325:
Treatment options continuedB. Disea
- Page 326 and 327:
Pain Management in Palliative CareP
- Page 328 and 329:
Subcutaneous analgesiaCalculate the
- Page 330 and 331:
Good prescribing points for transde
- Page 332 and 333:
Table continued from previous pageP
- Page 334 and 335:
Palliative Care - Last days of life
- Page 336 and 337:
Palliative CarePage 326
- Page 338 and 339:
Management of acute oncologicalcomp
- Page 340 and 341:
Continued from previous page• Pai
- Page 342 and 343:
Oncological EmergenciesTreatment /d
- Page 344 and 345:
Tumour Lysis SyndromeThis section d
- Page 346 and 347:
Malignant-related AscitesIntroducti
- Page 348 and 349:
Oncological EmergenciesPage 338
- Page 350 and 351:
AppendicesAppendix 1Nicotine Replac
- Page 352 and 353:
AppendicesAminophyllineIf intraveno
- Page 354 and 355:
AppendicesAppendix 3Therapeutic Dru
- Page 356 and 357:
AppendicesAppendix 4Mental Health L
- Page 358 and 359:
AppendicesAppendix 6Useful telephon
- Page 360 and 361:
AppendicesGlasgow Royal Infirmary (
- Page 362 and 363:
AppendicesSandyford Initiative (GUM
- Page 364 and 365:
IndexAAbbreviated Mental Test......
- Page 366 and 367:
Bites (human / animal)Treatment of
- Page 368 and 369:
ConstipationManagement of..........
- Page 370 and 371:
Gentamicin continuedInitial synergi
- Page 372 and 373:
InsulinIn DKA......................
- Page 374 and 375:
OlanzapineCautions / containdicatio
- Page 376 and 377:
Respiratory tract infections, treat
- Page 378 and 379:
Vancomycin continuedIn spontaneous
- Page 380 and 381:
Notes
- Page 382:
Notes